BRCA Mutation Status to Personalize Management of Recurrent Ovarian Cancer: A Multicenter Study

Detection of Germline Mutations in Patients with Epithelial Ovarian Cancer Using Multi-gene Panels: Beyond BRCA1/2

(2018) Kyung Jin Eoh et al.   Cancer Research and Treatment

Impact of primary platinum-free interval and BRCA1/2 mutation status on treatment and survival in patients with recurrent ovarian cancer

(2017) Michael A. Bookman et al.   GYNECOLOGIC ONCOLOGY

The First Nationwide Multicenter Prevalence Study of Germline BRCA1 and BRCA2 Mutations in Chinese Ovarian Cancer Patients

(2017) Xiaohua Wu et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Identification and Characterization of a New BRCA2 Rearrangement in an Italian Family with Hereditary Breast and Ovarian Cancer Syndrome

(2017) Paola Concolino et al.   Molecular Diagnosis & Therapy

Guidance Statement On BRCA1/2 Tumor Testing in Ovarian Cancer Patients

(2017) Ettore Capoluongo et al.   SEMINARS IN ONCOLOGY

BRCA to the future: towards best testing practice in the era of personalised healthcare

(2016) Ettore Capoluongo   EUROPEAN JOURNAL OF HUMAN GENETICS

Targeting the hallmarks of ovarian cancer: The big picture

(2016) M. Petrillo et al.   GYNECOLOGIC ONCOLOGY

Performance of multiplicom's BRCA MASTR Dx kit on the detection of BRCA1 and BRCA2 mutations in fresh frozen ovarian and breast tumor samples

(2016) Cindy Badoer et al.   Oncotarget

Prospective phase II trial of trabectedin in BRCA-mutated and/or BRCAness phenotype recurrent ovarian cancer patients: the MITO 15 trial

(2015) D. Lorusso et al.   ANNALS OF ONCOLOGY

Clinical impact on ovarian cancer patients of massive parallel sequencing forBRCAmutation detection: the experience at Gemelli hospital and a literature review

(2015) Angelo Minucci et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Positron Emission Tomography–Laparoscopy Based Method in the Prediction of Complete Cytoreduction in Platinum-Sensitive Recurrent Ovarian Cancer

(2014) Francesco Fanfani et al.   ANNALS OF SURGICAL ONCOLOGY

A preliminary Quality Control (QC) for next generation sequencing (NGS) library evaluation turns out to be a very useful tool for a rapid detection of BRCA1/2 deleterious mutations

(2014) Paola Concolino et al.   CLINICA CHIMICA ACTA

Latest research and treatment of advanced-stage epithelial ovarian cancer

(2013) Robert L. Coleman et al.   Nature Reviews Clinical Oncology

A Risk Model for Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer: An Evidence-Based Proposal for Patient Selection

(2011) Wen-Juan Tian et al.   ANNALS OF SURGICAL ONCOLOGY

Survival in epithelial ovarian cancer: a multivariate analysis incorporating BRCA mutation status and platinum sensitivity

(2010) D. J. Gallagher et al.   ANNALS OF ONCOLOGY

Upper abdominal surgery in advanced and recurrent ovarian cancer: Role of diaphragmatic surgery

(2009) Francesco Fanfani et al.   GYNECOLOGIC ONCOLOGY

“BRCAness” Syndrome in Ovarian Cancer: A Case-Control Study Describing the Clinical Features and Outcome of Patients With Epithelial Ovarian Cancer Associated WithBRCA1andBRCA2Mutations

(2008) David S.P. Tan et al.   JOURNAL OF CLINICAL ONCOLOGY

A Treatment Selection Protocol for Recurrent Ovarian Cancer Patients: The Role of FDG-PET/CT and Staging Laparoscopy

(2008) A. Fagotti et al.   ONCOLOGY